导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.99% | 676/1050 |
| 近一周 | -4.40% | 1016/1104 |
| 近一月 | -11.67% | 1075/1102 |
| 近一季 | -25.50% | 1056/1092 |
| 近半年 | -4.01% | 565/1070 |
| 近一年 | -0.62% | 599/1018 |
| 近两年 | 92.72% | 226/926 |
| 近三年 | 53.38% | 233/834 |
| 成立以来 | 57.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.77% 943/1070 |
54.79% 202/1101 |
- - |
- - |
| 2025 | 56.82% 133/1065 |
5.84% 352/1014 |
5.81% 251/1038 |
44.97% 128/1050 |
-3.41% 629/1065 |
| 2024 | 2.69% 510/1011 |
-7.31% 664/960 |
-3.24% 526/983 |
6.95% 823/991 |
7.05% 92/1011 |
| 2023 | -18.38% 632/952 |
7.39% 201/880 |
4.27% 45/895 |
-19.73% 862/915 |
-9.19% 823/952 |
| 2022 | -18.17% 261/867 |
-22.80% 663/773 |
23.08% 7/806 |
-0.89% 23/845 |
-13.12% 826/867 |
| 2021 | 23.06% 131/740 |
-16.22% 548/580 |
22.82% 124/659 |
22.42% 12/704 |
-2.30% 523/740 |
| 2020 | 19.27% 384/554 |
-11.73% 393/419 |
19.92% 287/466 |
-5.24% 463/517 |
18.90% 134/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 海富通先进制造股票C VS. 东吴新产业精选股票A(580008) |